v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development $ 5,135 $ 21,196 $ 10,949 $ 37,353
General and administrative 4,072 5,880 9,210 11,525
Total operating expenses 9,207 27,076 20,159 48,878
Loss from operations (9,207) (27,076) (20,159) (48,878)
Interest income 82 437 246 1,061
Change in fair value of warrant liability 3,980 13,620
Other income (expense), net 2,385 (84) 2,359 (147)
Total other income, net 6,447 353 16,225 914
Net loss and comprehensive loss $ (2,760) $ (26,723) $ (3,934) $ (47,964)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.1) $ (1.74) $ (0.14) $ (3.16)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.1) $ (1.74) $ (0.14) $ (3.16)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares) 28,696,937 15,333,962 28,684,447 15,178,904
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares) 28,696,937 15,333,962 28,684,447 15,178,904